tiprankstipranks
bioMerieux SA (FR:BIM)
:BIM
France Market

bioMerieux (BIM) Income Statement

Compare
6 Followers

bioMerieux Income Statement

Last quarter (Q2 2024), bioMerieux's total revenue was €1.90B, an increase of 14.71% from the same quarter last year. In Q2, bioMerieux's net income was €215.30M. See bioMerieux’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
€ 3.67B€ 3.59B€ 3.38B€ 3.12B€ 2.67B
Gross Profit
€ 2.06B€ 1.96B€ 1.97B€ 1.74B€ 1.45B
Operating Expenses
€ 1.62B€ 1.40B€ 1.20B€ 1.19B€ 1.12B
Depreciation and Amortization
€ 259.40M€ 257.60M€ 220.40M€ 228.40M€ 207.50M
EBITDA
€ 700.80M€ 811.90M€ 977.80M€ 747.70M€ 548.20M
Operating Income
€ 439.10M€ 559.80M€ 768.00M€ 551.20M€ 330.90M
Other Income/Expenses
€ -1.60M€ 20.70M€ -9.80M€ -26.80M€ 16.40M
Pretax Income
€ 437.50M€ 550.20M€ 748.30M€ 494.40M€ 318.60M
Net Income
€ 357.60M€ 452.40M€ 601.10M€ 404.40M€ 272.80M
Per Share Metrics
€ ―€ ―€ ―€ ―€ ―
Basic EPS
€ 3.03€ 3.84€ 5.08€ 3.42€ 2.31
Diluted EPS
€ 3.01€ 3.82€ 5.06€ 3.41€ 2.30
Weighted Average Shares Outstanding
118.15M 117.95M 118.27M 118.15M 118.30M
Weighted Average Shares Outstanding (Diluted)
118.80M 118.44M 118.89M 118.65M 118.71M
Currency in EUR

bioMerieux Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis